MedTrace Logo

A Cut-off Value Study of N-terminal Brain Natriuretic Peptide （Chemiluminescence Method）

NCT06691477 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1104

Last updated 2024-11-15

No results posted yet for this study

Summary

The aim of the study is to evaluate diagnostic performance of N-terminal Brain natriuretic Peptide (NT-proBNP) in acute heart failure among Chinese population. Further, it sought to explore the optimal cut-off point fitting Chinese patients.

Conditions

Interventions

OTHER

No Interventions

No intervention required. Subjects accepted regular medical treatment

Sponsors & Collaborators

  • Beckman Coulter, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-10
Primary Completion
2024-09-18
Completion
2024-10-11

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06691477 on ClinicalTrials.gov